Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects. [electronic resource]
Producer: 20061101Description: 232-8 p. digitalISSN:- 1554-8600
- AIDS Vaccines -- adverse effects
- Adult
- Anti-HIV Agents -- therapeutic use
- Fowlpox virus -- genetics
- Gene Products, gag -- genetics
- Gene Products, pol -- genetics
- Genetic Vectors
- HIV Antibodies
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Interferon-gamma -- administration & dosage
- Lymphocyte Subsets
- Male
- Middle Aged
- Vaccines, Synthetic -- adverse effects
- Viral Load
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.